Lv1
60 积分 2024-03-06 加入
Bisantrene in combination with fludarabine and clofarabine as salvage therapy for adult patients with refractory or relapsed acute myeloid leukaemia (AML)—An open‐label, phase I/II study
1天前
待确认
Bisantrene in combination with fludarabine and clofarabine as salvage therapy for adult patients with refractory or relapsed acute myeloid leukaemia (AML)—An open-label, phase I/II study
1天前
待确认
Clinical outcomes of allogeneic cell transplantation for patients with chronic myeloid leukemia
9天前
已完结
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial
10天前
已完结
Treatment of Relapsed and Refractory Follicular Lymphoma: Which Treatment for Which Patient for Which Line of Therapy?
1个月前
已关闭
Non-V600E BRAF mutations and treatment for hairy cell leukemia
5个月前
已关闭
Do we need another TKI for chronic myeloid leukaemia?
6个月前
已完结
Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting
7个月前
已完结
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual targeting antibody overcome antigen heterogeneity in AML
8个月前
已关闭
皖公网安备34019202002308
